Research

Original data & PubMed-cited science on GLP-1 weight loss.

We track every major GLP-1 telehealth provider in the United States and publish two kinds of long-form pieces: data investigations using our live dataset, and PubMed-cited scientific deep-dives on the studies that actually matter. Both update as the underlying data changes.

Research formats

Top-N PubMed lists
Ranked study reading lists
Curated 10-paper lists with PMIDs, NCT IDs, and editorial summaries for the most-searched topics.
Cheat sheets
Dose ladders, missed doses, red flags
Phone-friendly reference cards with every dose number sourced from the DailyMed FDA label.
Drug-vs-drug verdicts
Head-to-head comparisons
Short-form trial-anchored comparisons of the most-searched GLP-1 drug pairings.
Patient Q&A
Reddit questions, PubMed answers
Real patient questions from named subreddits, answered with peer-reviewed trial data and PMID citations.
Trial deep-dives
Every secondary endpoint decoded
Structured walkthroughs of pivotal GLP-1 trials with primary endpoint + all secondary endpoints + AE rates.
GLP-1 news
FDA approvals, trial readouts
Same-week coverage of FDA actions, Adcom votes, phase 3 trial data, payer policy changes, and class-action filings.

How we work

Every data point in our investigations is verified directly against provider websites, and the dataset updates continuously. Every scientific deep-dive cites primary literature from PubMed, the FDA, or peer-reviewed clinical trials — never blog summaries or marketing pages. Articles are reviewed and revised whenever the underlying evidence base changes.

We do not sell or recommend specific medical treatments — talk to a licensed clinician before starting any medication. Read our full methodology →